BE884813A - Furocoumarines pour la photochimiotherapie du psoriasis et d'autres maladies de la peau qui lui sont sensibles - Google Patents

Furocoumarines pour la photochimiotherapie du psoriasis et d'autres maladies de la peau qui lui sont sensibles

Info

Publication number
BE884813A
BE884813A BE6/47245A BE6047245A BE884813A BE 884813 A BE884813 A BE 884813A BE 6/47245 A BE6/47245 A BE 6/47245A BE 6047245 A BE6047245 A BE 6047245A BE 884813 A BE884813 A BE 884813A
Authority
BE
Belgium
Prior art keywords
furocoumarins
photochemotherapy
psoriasis
sensitive
skin diseases
Prior art date
Application number
BE6/47245A
Other languages
English (en)
Inventor
F Baccichetti
F Bordin
F Carlassare
F Dall Acqua
A Guiotto
G Pastorini
G Rodighiero
P Rodighiero
D Veladi
T B Fitzpatrick
J A Parrish
M A Pathak
K Wolff
Original Assignee
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale Ricerche filed Critical Consiglio Nazionale Ricerche
Publication of BE884813A publication Critical patent/BE884813A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE6/47245A 1979-08-20 1980-08-14 Furocoumarines pour la photochimiotherapie du psoriasis et d'autres maladies de la peau qui lui sont sensibles BE884813A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT84134/79A IT1166343B (it) 1979-08-20 1979-08-20 Furocumarina per la fotochemioterapia della fsoriasi e di altre malattie cutanee ad essa sensibili

Publications (1)

Publication Number Publication Date
BE884813A true BE884813A (fr) 1980-12-01

Family

ID=11324549

Family Applications (1)

Application Number Title Priority Date Filing Date
BE6/47245A BE884813A (fr) 1979-08-20 1980-08-14 Furocoumarines pour la photochimiotherapie du psoriasis et d'autres maladies de la peau qui lui sont sensibles

Country Status (10)

Country Link
US (1) US4312883A (fr)
JP (1) JPS5919957B2 (fr)
BE (1) BE884813A (fr)
CA (1) CA1162929A (fr)
DE (1) DE3031164C2 (fr)
FR (1) FR2463616A1 (fr)
GB (1) GB2061726B (fr)
IE (1) IE51692B1 (fr)
IT (1) IT1166343B (fr)
NL (1) NL190448C (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1165797B (it) * 1982-10-18 1987-04-29 Consiglio Nazionale Ricerche Procedimento di preparazione di alchilangelicine esenti da psoraleni ed alchilangolicine ottenute col procedimento
AT390559B (de) * 1982-10-18 1990-05-25 Consiglio Nazionale Ricerche Verwendung von neuen, psoralenfreien 6-methyl-angelicinen bzw. von deren salzen fuer die herstellung von arzneimitteln
US5179217A (en) * 1982-10-18 1993-01-12 Francarosa Baccichetti Method of preparing photochemotherapic alkylangelicin compounds
JPS6146451A (ja) * 1984-08-11 1986-03-06 Toshiba Corp スタ−リングエンジン
US4647666A (en) * 1985-04-01 1987-03-03 Iowa State University Research Foundation, Inc. Heterocyclic synthesis via thallation and subsequent palladium-promoted olefination
US4650881A (en) * 1985-04-01 1987-03-17 Iowa State University Research Foundation, Inc. Synthesis of isocoumarins via thallation-olefination of arenes
WO1990008529A2 (fr) * 1989-01-23 1990-08-09 Lehigh University 7-alkoxycoumarines, dihydropsoralenes et benzodipyranones constituant des agents therapetiques photosensibilises et des inhibiteurs de facteur de croissance epidermique
US5356929A (en) * 1989-01-23 1994-10-18 Lehigh University Reduced and quaternized psoralens as photo-activated therapeutics
US5139940A (en) * 1989-10-26 1992-08-18 Isaacs Stephen T Activation compounds and methods of synthesis of activation compounds
ATE180281T1 (de) * 1989-10-26 1999-06-15 Stephen T Isaacs Verfahren zur hemmung der enzymatischen herstellung von nukleinsäuren mittels isopsoralene
US5503721A (en) 1991-07-18 1996-04-02 Hri Research, Inc. Method for photoactivation
US5221608A (en) * 1989-10-26 1993-06-22 Cimino George D Methods for rendering amplified nucleic acid subsequently unamplifiable
US5372929A (en) * 1992-01-27 1994-12-13 Cimino; George D. Methods for measuring the inactivation of pathogens
US6433343B1 (en) 1992-03-02 2002-08-13 Cerus Corporation Device and method for photoactivation
US5556612A (en) * 1994-03-15 1996-09-17 The General Hospital Corporation Methods for phototherapeutic treatment of proliferative skin diseases
US5780446A (en) * 1996-07-09 1998-07-14 Baylor College Of Medicine Formulations of vesicant drugs and methods of use thereof
US20070099170A1 (en) * 1998-07-21 2007-05-03 Navigant Biotechnologies, Inc. Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US20030215784A1 (en) * 1998-07-21 2003-11-20 Dumont Larry Joe Method and apparatus for inactivation of biological contaminants using photosensitizers
US6277337B1 (en) 1998-07-21 2001-08-21 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US7049110B2 (en) * 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US7498156B2 (en) * 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
US7648699B2 (en) * 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
TW590780B (en) * 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7985588B2 (en) * 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US6843961B2 (en) * 2000-06-15 2005-01-18 Gambro, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
ITMI20010685A1 (it) * 2001-03-30 2002-09-30 Biochimici Psn S P A Acido delta-amminolevulinico per uso medico e cosmetico
US6924373B2 (en) * 2003-05-02 2005-08-02 Asiagen Corporation DNA labeling reagents, acridinium-9-carboxamide derivatives and process of preparing DNA labeling compounds
AU2007292302A1 (en) * 2006-09-05 2008-03-13 Bipar Sciences, Inc. Methods for designing PARP inhibitors and uses thereof
ITVE20070005A1 (it) 2007-01-25 2008-07-26 Associazione Veneta Per La Lotta Alla Talassemia Farmaco per la cura della talassemia, dell'anemia falciforme e di tutte le altre forme di anemia trattabili con questo, metodo di attivazione del farmaco, composizione farmaceutica avente come principio attivo il farmaco e metodo fotochemioterapico u
EP2205285A2 (fr) * 2007-08-01 2010-07-14 CaridianBCT Biotechnologies, LLC Inactivation de pathogènes du sang entier
WO2009026073A1 (fr) * 2007-08-22 2009-02-26 Caridianbct Biotechnologies, Llc Prévention d'une lésion aiguë des poumons liée à une transfusion en utilisant de la riboflavine et de la lumière
US20090312406A1 (en) * 2008-06-12 2009-12-17 Hsing-Pang Hsieh Coumarin compounds and their use for treating viral infection
US8058427B2 (en) * 2008-06-12 2011-11-15 National Health Research Institutes Coumarin compounds and their use for treating cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5298000A (en) * 1976-02-12 1977-08-17 Yoshitomi Pharmaceut Ind Ltd Preparation of novel dihydrofurocoumarin derivatives
JPS5297999A (en) * 1976-02-12 1977-08-17 Yoshitomi Pharmaceut Ind Ltd Dihydrofurocoumarin derivatives

Also Published As

Publication number Publication date
IT1166343B (it) 1987-04-29
DE3031164C2 (de) 1986-08-21
GB2061726A (en) 1981-05-20
NL190448B (nl) 1993-10-01
US4312883A (en) 1982-01-26
NL190448C (nl) 1994-03-01
JPS5630982A (en) 1981-03-28
FR2463616A1 (fr) 1981-02-27
NL8004699A (nl) 1981-02-24
JPS5919957B2 (ja) 1984-05-09
GB2061726B (en) 1983-10-26
IE51692B1 (en) 1987-02-18
CA1162929A (fr) 1984-02-28
FR2463616B1 (fr) 1984-04-27
IE801747L (en) 1981-02-20
DE3031164A1 (de) 1981-03-12
IT7984134A0 (it) 1979-08-20

Similar Documents

Publication Publication Date Title
BE884813A (fr) Furocoumarines pour la photochimiotherapie du psoriasis et d'autres maladies de la peau qui lui sont sensibles
DK473877A (da) Fremgangsmaade til in situ at diagnosticere sygelige forandringer i et menneskelegemes bloeddele fortrinsvis kvindebrystet samt apparat til udoevelse af fremangsmaaden
BE892299A (fr) Composition cosmetique pour le traitement des cheveux et de la peau
FR2496458B1 (fr) Composition huileuse destinee au traitement des matieres keratiniques et de la peau
BE858404A (fr) Traitement de l'affection dermatologique dite "peau seche"
BE895718A (fr) Composition d'anthralines dans un ester aromatique et utilisation dans le traitement des maladies de la peau et des ongles
DK152086C (da) Hudelektrode og fremgangsmaade ved fremstilling deraf
IT1159685B (it) Composizione per regolare l'escrezione fecale di soggetti umani
IT8868118A0 (it) Composizione e procedimento per il trattamento e la cura dei capelli
BE877629A (fr) Compositions cosmetiques a base de dithioethers pour le traitement de l'etat gras des cheveux et de la peau
TR20232A (tr) Cis-9-trikosen ve metomil'den olusan ensektisit bilesim
GB2003470B (en) Treatment of skin diseases
BE891319A (fr) Electrodeposition du palladium et d'alliages de palladium
FR2347943A1 (fr) Appareil d'irradiation destine au traitement de maladies de la peau
DK31386A (da) Behandling af proliferative hudsygdomme
PH12964A (en) Pyranochromone derivatives and therapeutic composition comprising same for treatment of allergic diseases
BE860992A (fr) Composition et tampon pour le traitement ou la prevention de l'acne et d'affections de la peau similaires
DK165664C (da) Psoralen-badpraeparat til behandling af psoriasis og andre hudsygdomme
DK318880A (da) Fungicidt virksomme thioglycolsyreanilider deres fremstilling og anvendelse
AU516531B2 (en) Method and composition forthe therapy of cerebral circulatory diseases
FR2338034A1 (fr) Nouveau procede cosmetique pour ameliorer l'aspect des cheveux gras et/ou des peaux grasses
DK296379A (da) 2-cyclopropyl-pyrimidin-(4)-yl-thionophosphonsyreestere deres fremstilling og anvendelse
GB2055044B (en) Glucuronidase activity and/or phdependent pharmaceuticals and their methods of production and use for selective treatment of diseases
SU634736A1 (ru) Первичный преобразователь временных характеристик ходьбы и бега человека
IT7869700A0 (it) Medicamento per il trattamento dell'ateroma e delle angiopatie

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: CONSIGLIO NAZIONALE DELLE RICERCHE

Effective date: 19950831